Skip to main content
SpringerLink
Log in

Cardiovascular Disease

  • Chapter
Geriatric Medicine

Abstract

Aging of populations, common in the industrialized world, is rapidly becoming a characteristic of developing nations as well. Two thirds of the world’s 600 million people aged 60 years or older are projected to reside in developing nations by the year 2000. Not only is the elderly population increasing worldwide, but the aged population itself is becoming older as more people survive to older ages. Cardiovascular disease increases dramatically with aging and is the major cause of death and disability in elderly persons; 83% of all cardiovascular deaths in the United States occur in patients older than 65 years of age.1 Coronary heart disease is the most prevalent cardiac problem, followed by hypertensive cardiovascular disease. The problem facing all societies is how to pay for the care, rather than the cure, that is characteristic of chronic illness. Elderly patients constitute a highly heterogeneous group, with widely differing functional status, severities of illness, expectations of medical therapy, and psychosocial needs, none of which relates substantially either to each other or to chronologic age. Recent data suggest that the management and outcomes for most patients aged 65 to 75 years are comparable to that for their younger counterparts, but that cardiovascular diagnosis and therapy must be highly individualized beyond this age. The challenge is to identify the characteristics of people who remain active, alert, and energetic into old age, and to determine how lifestyle components, including nutrition, obesity, exercise, psychosocial features, work, retirement, and others, affect aging. This information can guide the preventive measures that may decrease disability in later life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. National Center for Health Statistics. Advance report of final mortality statistics, 1988. In: Monthly Vital Statistics Report, vol. 39, no. 7 suppl. Hyattsville, MD: Public Health Service; 1990: 1–48.

    Google Scholar 

  2. Fleg JL, Lakatta EG. Role of muscle loss in the age-associated reduction in VO2 max. J Appl Physiol. 1988; 65: 1147–1151.

    PubMed  CAS  Google Scholar 

  3. Lernfelt B, Wikstrand J, Svanborg A, et al. Aging and left ventricular function in elderly healthy people. Am J Cardiol. 1991; 68: 547–549.

    Article  PubMed  CAS  Google Scholar 

  4. Mader SL, Josephson KR, Rubenstein LZ. Low prevalence of postural hypotension among community-dwelling elderly. JAMA. 1987; 258: 1511–1514.

    Article  PubMed  CAS  Google Scholar 

  5. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. Hypertension. 1992; 19 (part 1): 508–519.

    Article  PubMed  CAS  Google Scholar 

  6. Bild DE, Fitzpatrick A, Fried LP, et al. Age-related trends in cardiovascular morbidity and physical functioning in the elderly: The Cardiovascular Health Study. J Am Geriatr Soc. 1993; 41: 1047–1056.

    PubMed  CAS  Google Scholar 

  7. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation. 1993; 88: 837–845.

    Article  PubMed  CAS  Google Scholar 

  8. Gerstenblith G. Noninvasive assessment of cardiac function in the elderly. In Weisfeldt M, ed. The Aging Heart: Its Function and Response to Stress. New York: Raven Press; 1984: 247–267.

    Google Scholar 

  9. Furberg CD, Manolio TA, Psaty BM, et al. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Am J Cardiol. 1992; 69: 1329–1335.

    Article  PubMed  CAS  Google Scholar 

  10. Ingerslev J, Bjerregaard P. Prevalence and prognostic significance of cardiac arrhythmias detected by ambulatory electrocardiography in subjects 85 years of age. Eur Heart J. 1986; 7: 570–575.

    PubMed  CAS  Google Scholar 

  11. Come PC, Riley MF, McKay RG, et al. Echocardiographic assessment of aortic valve area in elderly patients with aortic stenosis and of changes in valve area after per-cutaneous balloon valvuloplasty. J Am Coll Cardiol. 1987; 10: 115–124.

    Article  PubMed  CAS  Google Scholar 

  12. Deckers JW, Simoons ML, Fioretti P. The value of exercise testing in elderly patients. Ger Cardiovasc Med. 1988; 1: 89–93.

    Google Scholar 

  13. Lam JYT, Chaitman BR, Glaenzer M. Safety and diagnostic accuracy in dipyridamole-thallium imaging in the elderly. J Am Coll Cardiol. 1988; 11: 585–589.

    Article  PubMed  CAS  Google Scholar 

  14. Iskandrian AS, Heo J, Decoskey D, et al. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease. Am J Cardiol. 1988; 61: 269–272.

    Article  PubMed  CAS  Google Scholar 

  15. Smith WM. Epidemiology of congestive heart failure. Am J Cardiol. 1985; 55: 3A - 8A.

    Article  PubMed  CAS  Google Scholar 

  16. Konstam MA, Dracup K, Baker D, et al. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. Clinic Practice Guideline No. 11. AHCPR Publication No. 94–0612. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services; June 1994.

    Google Scholar 

  17. Wenger NK, Franciosa JA, Weber KT. 18th Bethesda Conference. Cardiovascular disease in the elderly. Heart failure. J Am Coll Cardiol. 1987;10(suppl A):73A76A.

    Google Scholar 

  18. Wong WF, Gold S, Fukuyama O, et al. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol. 1989; 63: 1526–1528.

    Article  PubMed  CAS  Google Scholar 

  19. Kessler KM. Heart failure with normal systolic function. Update of prevalence, differential diagnosis, prognosis and therapy (editorial). Arch Intern Med. 1988; 148: 2109–2111.

    Article  PubMed  CAS  Google Scholar 

  20. Cody RJ, Torre S, Clark M, et al. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure. Arch Intern Med. 1989; 149: 1023–1028.

    Article  PubMed  CAS  Google Scholar 

  21. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316: 1429–1435.

    Google Scholar 

  22. Furberg CD, Yusuf S, Thom TJ. Potential for altering the natural history of congestive heart failure. Am J Cardiol. 1985; 55: 45A - 47A.

    Article  PubMed  CAS  Google Scholar 

  23. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991; 325: 293–302.

    Article  Google Scholar 

  24. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991; 325: 303–310.

    Article  PubMed  CAS  Google Scholar 

  25. Chapman D, Wang T, Gheorghiade M. Therapeutic approaches to heart failure in elderly patients. Cardiol Elderly. 1994; 2: 89–97.

    Google Scholar 

  26. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med. 1993; 329: 1–7.

    Article  PubMed  CAS  Google Scholar 

  27. Giannuzzi P, Tavazzi L, Temporelli PL, et al., for the EAMI Study Group. Long-term physical training and left ventricular remodeling after anterior myocardial infarction: results of the Exercise in Anterior Myocardial Infarction (EAMI) Trial. J Am Coll Cardiol. 1993; 22: 1821–1829.

    Article  PubMed  CAS  Google Scholar 

  28. Marcus FI, Ruskin JN, Surawicz B. 18th Bethesda Conference. Cardiovascular disease in the elderly. Arrhythmias. J Am Coll Cardiol. 1987; 10 (suppl A): 66A - 72A.

    Article  PubMed  CAS  Google Scholar 

  29. Bharati S, Lev M. Pathologic changes of the conduction system with aging. Cardiol Elderly. 1994; 2: 152–160.

    Google Scholar 

  30. Lipsitz LA, Wei JY, Rowe JW. Syncope in an elderly institutionalized population: prevalence, incidence, and associated risk. Q J Med. 1985; 55: 45–54.

    PubMed  CAS  Google Scholar 

  31. Gordon M, Huang M, Gryfe CI. An evaluation of falls, syncope and dizziness in prolonged ambulatory cardiographic monitoring in a geriatric institutional setting. J Am Geriatr Soc. 1982; 30: 6–12.

    PubMed  CAS  Google Scholar 

  32. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. Arch Intern Med. 1987; 147: 1561–1564.

    Article  PubMed  CAS  Google Scholar 

  33. The Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation. 1991; 84: 527–539.

    Google Scholar 

  34. Aronow WS, Mercando AD, Epstein S, et al. Effect of quinidine or procainamide versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in elderly patients with heart disease and complex ventricular arrhythmias. Am J Cardiol. 1990; 66: 423–428.

    Article  PubMed  CAS  Google Scholar 

  35. Tresch DD, Troup PJ, Thakur RK, et al. Comparison of efficacy of automatic implantable cardioverter defibrillator in patients older and younger than 65 years of age. Am J Med. 1991; 90: 717–724.

    PubMed  CAS  Google Scholar 

  36. Shen W-K, Hayes DL. Pacing the octogenarians and nonagenarians: Should age be a consideration for pacing and outcome analysis of pacing in the very elderly? Cardiol Elderly. 1994; 2: 161–170.

    Google Scholar 

  37. Dreifus LS, Fisch C, Griffin JC, et al. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/ American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation). J Am Coll Cardiol. 1991; 18: 1–13.

    Article  PubMed  CAS  Google Scholar 

  38. Wenger NK, Furberg CD, Pitt E. Coronary Heart Disease in the Elderly: Working Conference on the Recognition and Management of Coronary Heart Disease in the Elderly, National Institutes of Health, Bethesda 1985. New York: Elsevier Science; 1986.

    Google Scholar 

  39. Graves EJ. Summary, 1989 National Hospital Discharge Survey: Advance Data from Vital and Health Statistics, no. 199. Hyattsville, MD; National Center for Health Statistics; 1991: 1–12.

    Google Scholar 

  40. Umachandran V, Ranjadayalan K, Ambepityia G, et al. Aging, autonomic function, and the perception of angina. Br Heart J. 1991; 66: 15–18.

    Article  PubMed  CAS  Google Scholar 

  41. LaCroix AZ, Guralnik JM, Curb JD, et al. Chest pain and coronary heart disease mortality among older men and women in three communities. Circulation. 1990; 81: 437–446.

    Article  PubMed  CAS  Google Scholar 

  42. Pepine CJ, Abrams J, Marks RG, et al., for the TIDES Investigators. Characteristics of a contemporary population with angina pectoris. Am J Cardiol. 1994; 74: 226–231.

    Article  PubMed  CAS  Google Scholar 

  43. Mittelmark MB, Psaty BM, Rautaharju PM, et al. Prevalence of cardiovascular diseases among older adults. The Cardiovascular Health Study. Am J Epidemiol. 1993; 137: 311–317.

    PubMed  CAS  Google Scholar 

  44. Nadelmann J, Frishman WH, Ooi WL, et al. Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. Am J Cardiol. 1990; 66: 533–537.

    Article  PubMed  CAS  Google Scholar 

  45. Solomon CG, Lee TH, Cook EF, et al. Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: The Multicenter Chest Pain Study experience. Am J Cardiol. 1989; 63: 772–776.

    Article  PubMed  CAS  Google Scholar 

  46. Hong RA, Licht JD, Wei JY, et al. Elevated CK-MB with normal total creatine kinase in suspected myocardial infarction: associated clinical findings and early prognosis. Am Heart J. 1986; 111: 1041–1047.

    Article  PubMed  CAS  Google Scholar 

  47. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet. 1987; 2: 871–874.

    Google Scholar 

  48. Wilcox RG, von der Lippe G, Olsson CG, et al., for the Anglo-Scandinavian Study of Early Thrombolysis. Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Lancet. 1990; 335: 1175 1178.

    Google Scholar 

  49. AIMS Trial Study Group. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet. 1990; 335: 427–431.

    Google Scholar 

  50. Chaitman BR, Thompson B, Wittry MD, et al. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from Thrombolysis in Myocardial Infarction Phase I, open label studies, and the Thrombolysis in Myocardial Infarction Phase II pilot study. J Am Coll Cardiol. 1989; 14: 1159–1165.

    Article  PubMed  CAS  Google Scholar 

  51. The International Study Group. In-hospital mortality and clinicalcourse of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. Lancet. 1990; 336: 71–75.

    Article  Google Scholar 

  52. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI-2). A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet. 1990; 336: 65–71.

    Google Scholar 

  53. Gore JM, Sloan M, Price TR, et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study: Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Circulation. 1991; 83: 448–459.

    Article  PubMed  CAS  Google Scholar 

  54. Weaver WD, Litwin PE, Martin JS, et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol. 1991; 18: 657–662.

    Article  PubMed  CAS  Google Scholar 

  55. Pfeffer MA, Moye LA, Braunwald E, et al. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. JA MA. 1991; 266: 528–532.

    CAS  Google Scholar 

  56. Maggioni AP, Maseri A, Fresco C, et al., on behalf of the Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI-2). Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. N Engl J Med. 1993; 329: 1442–1448.

    Article  PubMed  CAS  Google Scholar 

  57. Forman DE, Bernal JLG, Wei JY. Management of acute myocardial infarction in the very elderly. Am J Med. 1992; 93: 315–326.

    Article  PubMed  CAS  Google Scholar 

  58. Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA. 1993; 270: 1832–1836.

    Article  PubMed  CAS  Google Scholar 

  59. Smith SC Jr, Gilpin E, Ahnve S, et al. Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years. J Am Coll Cardiol. 1990; 16: 784–792.

    Article  PubMed  Google Scholar 

  60. MacMahon S, Collins R, Peto R, et al. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA. 1988; 260: 1910–1916.

    Article  PubMed  CAS  Google Scholar 

  61. Gundersen T, Abrahamsen AM, Kjekshus J, et al., for the Norwegian Multicentre Study Group. Timolol-related reduction in mortality and reinfarction in patients ages 65–75 years surviving acute myocardial infarction. Circulation. 1982; 66: 1179–1184.

    Article  PubMed  CAS  Google Scholar 

  62. Gurwitz JH, Goldberg RJ, Chen Z, et al. ß-Blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med. 1992; 93: 605–610.

    Article  PubMed  CAS  Google Scholar 

  63. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988; 2: 349–360.

    Google Scholar 

  64. Pfeffer MA, Braunwald E, Moyé LA, et al., on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992; 327: 669–677.

    Article  PubMed  CAS  Google Scholar 

  65. Second Report of the Sixty-Plus Reinfarction Group. Risk of long-term anticoagulant therapy in elderly patients after myocardial infarction. Lancet. 1982; 1: 64–68.

    Google Scholar 

  66. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med. 1990; 323: 147–152.

    Article  PubMed  CAS  Google Scholar 

  67. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991; 324: 781–788.

    Article  PubMed  CAS  Google Scholar 

  68. Fioretti P, Deckers JW, Brower RW, et al. Predischarge stress test after myocardial infarction in old age: results and prognostic value. Eur Heart J. 1984; 5 (suppl E): 101–104.

    Article  PubMed  Google Scholar 

  69. Wenger NK. Populations with special needs for exercise rehabilitation. Elderly coronary patients. In: Wenger NK, Hellerstein HK, eds. Rehabilitation of the Coronary Patient. 3d ed. New York: Churchill-Livingstone; 1992: 415–420.

    Google Scholar 

  70. Lavie CJ, Milani RV, Littman AB. Benefits of cardiac rehabilitation and exercise training in secondary coronary prevention in the elderly. J Am Coll Cardiol. 1993; 22: 678–683.

    Article  PubMed  CAS  Google Scholar 

  71. Ades PA, Waldmann ML, Poehlman ET, et al. Exercise conditioning in older coronary patients: submaximal lactate response and endurance capacity. Circulation. 1993; 88: 572–577.

    Article  PubMed  CAS  Google Scholar 

  72. O’Keefe JH Jr, Sutton MB, McCallister BD, et al. Coronary angioplasty versus bypass surgery in patients 70 years old matched for ventricular function. J Am Coll Cardiol. 1994; 24: 425–430.

    Article  PubMed  Google Scholar 

  73. Naunheim KS, Dean PA, Firoe AC, et al. Cardiac surgery in the octogenarian. Eur J Cardiothorac Surg. 1990; 4: 130–135.

    Article  PubMed  CAS  Google Scholar 

  74. Weintraub WS, Clements SD, Ware J, et al. Coronary artery surgery in octogenarians. Am J Cardiol. 1991; 68: 1530–1534.

    Article  PubMed  CAS  Google Scholar 

  75. Glower DD, Christopher TD, Milano CA, et al. Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years. Am J Cardiol. 1992; 70: 567–571.

    Article  PubMed  CAS  Google Scholar 

  76. Ko W, Gold JP, Lazzaro R, et al. Survival analysis of octogenarian patients with coronary artery disease managed by elective coronary artery bypass surgery versus conventional medical treatment. Circulation. 1992; 86(suppl II):II-191-II-197.

    Google Scholar 

  77. Horvath KA, DiSesa VJ, Peigh PS, et al. Favorable results of coronary artery bypass grafting in patients older than 75 years. J Thorac Cardiovasc Surg. 1990; 99: 92–96.

    PubMed  CAS  Google Scholar 

  78. Gersh BJ, Kronmal RA, Schaff HV, et al., and participants in the CASS Study. Comparison of coronary artery surgery and medical therapy in patients 65 years of age or older: a nonrandomized study from the Coronary Artery Surgery Study (CASS) Registry. N Engl J Med. 1985; 313: 217–224.

    Article  PubMed  CAS  Google Scholar 

  79. Kelsey SF, Miller DP, Holubkov R, et al. Results of percutaneous transluminal coronary angioplasty in patients 65 years of age (from the 1985 to 1986 National Heart, Lung, and Blood Institute’s Coronary Angioplasty Registry). Am J Cardiol. 1990; 66: 1033–1038.

    Article  PubMed  CAS  Google Scholar 

  80. Bedotto JB, Rutherford BD, McConahay DR, et al. Results of multivessel percutaneous transluminal coronary angioplasty in persons aged 65 years and older. Am J Cardiol. 1991; 67: 1051–1055.

    Article  PubMed  CAS  Google Scholar 

  81. Jackman JD, Navetta FI, Smith JE, et al. Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectoris. Am J Cardiol. 1991; 68: 116–119.

    Article  PubMed  Google Scholar 

  82. Weyrens FJ, Goldenberg I, Mooney JF, et al. Percutaneous transluminal coronary angioplasty in patients aged 90 years. Am J Cardiol. 1994; 74: 397–398.

    Article  PubMed  CAS  Google Scholar 

  83. National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. Hypertension. 1994; 23: 275–285.

    Article  Google Scholar 

  84. Staessen J, Amery A, Fagard R. Editorial review. Isolated systolic hypertension in the elderly. J Hypertens. 1990; 8: 393–405.

    Article  PubMed  CAS  Google Scholar 

  85. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension, III: Influence of age, diastolic pressure, and prior cardiovascular disease: further analysis of side effects. Circulation. 1972; 45: 991–1004.

    Google Scholar 

  86. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet. 1985; 1: 1349–1354.

    Article  PubMed  CAS  Google Scholar 

  87. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265: 3255–3264.

    Article  Google Scholar 

  88. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993; 153: 154–183.

    Google Scholar 

  89. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994; 121: 289–300.

    PubMed  CAS  Google Scholar 

  90. Staessen J, Fagard R, Lijnen P, et al. Review of the major hypertension trials in the elderly. Cardiovasc Drugs Ther. 1990; 4 (suppl 6): 1237–1247.

    Article  Google Scholar 

  91. Culliford AT, Galloway AC, Colvin SB, et al. Aortic valve replacement for aortic stenosis in persons aged 80 years and over. Am J Cardiol. 1991; 67: 1256–1260.

    Article  PubMed  CAS  Google Scholar 

  92. Nylander E, Ekman I, Marklund T, et al. Severe aortic stenosis in elderly patients. Br Heart J. 1986; 55: 480–487.

    Article  PubMed  CAS  Google Scholar 

  93. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988; 9 (suppl E): 57–64.

    Article  PubMed  Google Scholar 

  94. Lombard JT, Selzer A. Valvular aortic stenosis: a clinical and hemodynamic profile of patients. Ann Intern Med. 1987; 606: 292–298.

    Google Scholar 

  95. Lund O, Neilsen TT, Magrussen K, et al. Valve replacement for calcified aortic stenosis in septuagenarians infers normal life-length. Scand J Cardiovasc Surg. 1991; 25: 37–44.

    Article  CAS  Google Scholar 

  96. Aranki SF, Rizzo RJ, Couper GS, et al. Aortic valve replacement in the elderly. Effect of gender and coronary artery disease on operative mortality. Circulation. 1993; 88 (part 2): 17–23.

    Google Scholar 

  97. Craver JM, Weintraub WS, Jones EL, et al. Predictors of mortality, complications, and length of stay in aortic valve replacement for aortic stenosis. Circulation. 1988;78(suppl I):1–85-I-90.

    Google Scholar 

  98. McKay CR, Waller BF. Current status of balloon valvuloplasty. Cardiol Elderly. 1993; 1: 77–85.

    Google Scholar 

  99. O’Neill WW, for the Mansfield Scientific Aortic Valvuloplasty Registry Investigators. Predictors of longterm survival after percutaneous aortic valvuloplasty: report of the Mansfield Scientific Balloon Aortic Valvuloplasty Registry. J Am Coll Cardiol. 1991; 17: 193–198.

    Article  PubMed  Google Scholar 

  100. Kolibash AJ, Bush CA, Fontana MB, et al. Mitral valve prolapse syndrome: analysis of 62 patients aged 60 years and older. Am J Cardiol. 1983; 52: 534–539.

    Article  PubMed  CAS  Google Scholar 

  101. Hochberg MS, Derkac WM, Conkle DM, et al. Mitral valve replacement in elderly patients: encouraging postoperative clinical and hemodynamic results. J Thorac Cardiovasc Surg. 1979; 77: 422–426.

    PubMed  CAS  Google Scholar 

  102. Tsai TP, Matloff JM, Chaux A, et al. Combined valve and coronary artery bypass procedures in septuagenarians and octogenarians: results in 120 patients. Ann Thorac Surg. 1986; 42: 681–684.

    Article  PubMed  CAS  Google Scholar 

  103. Freeman WK, Schaff HV, O’Brien PC, et al. Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol. 1991; 18: 29–35.

    Article  PubMed  CAS  Google Scholar 

  104. Cheitlin MD. Congenital heart disease in the adult. Mod Conc Cardiovasc Dis. 1986; 55: 20–24.

    Google Scholar 

  105. Terpenning MS, Buggy BP, Kauffman CA. Infective endocarditis: clinical features in young and elderly patients. Am J Med. 1987; 83: 626–634.

    Article  PubMed  CAS  Google Scholar 

  106. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis: Recommendations by the American Heart Association. JAMA. 1990; 264: 2919–2922.

    Article  PubMed  CAS  Google Scholar 

  107. Kearney RA, Eisen HJ, Wolf JE. Nonvalvular infections of the cardiovascular system. Ann Intern Med. 194; 121: 219–230.

    Google Scholar 

  108. Krasnow N, Stein RA. Hypertrophic cardiomyopathy in the aged. Am Heart J. 1978; 96: 326–336.

    Article  PubMed  CAS  Google Scholar 

  109. Lewis JF, Maron BJ. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients _65 years of age. Am J Cardiol. 1994; 73: 1105–1111.

    Article  PubMed  CAS  Google Scholar 

  110. Shah PM, Abelmann WH, Gersh BJ. 18th Bethesda Conference. Cardiovascular Disease in the Elderly. Cardiomyopathies in the elderly. J Am Coll Cardiol. 1987; 10 (suppl A): 77A - 79A.

    Article  PubMed  CAS  Google Scholar 

  111. Stein PD, Gottschalk A, Saltzman HA, et al. Diagnosis of acute pulmonary embolism in the elderly. J Am Coll Cardiol. 1991; 18: 1452–1457.

    Article  PubMed  CAS  Google Scholar 

  112. Burrows B, Alpert JS, Ross JC. 18th Bethesda Conference. Cardiovascular Disease in the Elderly. Pulmonary heart disease. J Am Coll Cardiol. 1987;10(suppl A):63A65A.

    Google Scholar 

  113. Lowenthal DT, Affrime MB. Cardiovascular drugs for the geriatric patient. Geriatrics. 1981; 36: 65–74.

    PubMed  CAS  Google Scholar 

  114. Lavarenne J, Dumas R, Cayrol C. Effets indésirables des médicaments chez les personnes âgées. Bilan des observation recueilliés pendant un an par l’Association Française des Centres de Pharmacovigilance. Therapie. 1993; 38: 485–493.

    Google Scholar 

  115. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program: II. Mortality by race-sex and age. JAMA. 1979; 242: 2572–2577.

    Article  Google Scholar 

  116. Black DM, Brand RJ, Greenlick M, et al. Compliance to treatment for hypertension in elderly patients: The SHEP Pilot Study. J Gerontol. 1987; 42: 552–557.

    Article  PubMed  CAS  Google Scholar 

  117. Schwartz JB, Abernethy DR. Cardiac drugs: adjusting their use in aging patients. Geriatrics. 1987; 42: 31–40.

    PubMed  CAS  Google Scholar 

  118. Vestal RE, Wood AJ, Shand DG. Reduced betaadrenoreceptor sensitivity in the elderly. Clin Pharmacol Ther. 1979; 26: 181–186.

    PubMed  CAS  Google Scholar 

  119. Gerson MC, Hurst JM, Hertzberg VS, et al. Cardiac prognosis in noncardiac geriatric surgery. Ann Intern Med. 1985; 103: 832–837.

    PubMed  CAS  Google Scholar 

  120. Mangano DT. Perioperative cardiac morbidity. Anesthesiology. 1990; 72: 153–184.

    Article  PubMed  CAS  Google Scholar 

  121. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977; 197: 845–850.

    Article  Google Scholar 

  122. Freeman WK, Gibbons RJ, Shub C. Preoperative assessment of cardiac patients undergoing noncardiac surgical procedures. Mayo Clin Proc. 1989; 64: 1105–1117.

    Article  PubMed  CAS  Google Scholar 

  123. Gersh BJ, Rihal CS, Rooke TW, et al. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol. 1991; 18: 203214.

    Google Scholar 

  124. Towne JB, Weiss DG, Hobson RW II. First phase report of Cooperative Veterans Administration Asymptomatic Carotid Stenosis Study: operative morbidity and mortality. J Vasc Surg. 1990; 11: 252–259.

    PubMed  CAS  Google Scholar 

  125. Kannel WB, Doyle JT, Shephard RJ, et al. 18th Bethesda Conference. Cardiovascular Disease in the Elderly. Prevention of cardiovascular disease in the elderly. J Am Coll Cardiol. 1987; 10 (suppl A): 25A - 28A.

    Article  PubMed  CAS  Google Scholar 

  126. Snowdon DA, Phillips RL, Fraser GE. Meat consumption and fatal ischemic heart disease. Prey Med. 1984; 13: 490500.

    Google Scholar 

  127. The Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993; 269: 30153025.

    Google Scholar 

  128. Denke MA, Grundy SM. Hypercholesterolemia in elderly persons: resolving the treatment dilemma. Ann Intern Med. 1990; 112: 780–792.

    PubMed  CAS  Google Scholar 

  129. Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand. 1988; 223: 405–418.

    Article  PubMed  CAS  Google Scholar 

  130. Jajich CL, Ostfeld AM, Freeman DH Jr. Smoking and coronary heart disease mortality in the elderly. JAMA. 1984; 252: 2831–2834.

    Article  PubMed  CAS  Google Scholar 

  131. Hermanson B, Omenn GS, Kronmal RA, et al. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS Registry. N Engl J Med. 1988; 319: 1365–1369.

    Article  PubMed  CAS  Google Scholar 

  132. Reaven PD, Barrett-Connor E, Edelstein S. Relation between leisure-time physical activity and blood pressure in older women. Circulation. 1991; 83: 559–565.

    Article  PubMed  CAS  Google Scholar 

  133. Pollock ML, Carroll JF, Graves JE, et al. Injuries and adherence to walk/jog and resistance training programs in the elderly. Med Sci Sports Exerc. 1991; 23: 1194–1200.

    PubMed  CAS  Google Scholar 

  134. Manolio TA, Furberg CD, Shemanski L, et al., for the CHS Collaborative Research Group. Association of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation. 1993; 88 (part 1): 2163–2171.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Nanette Kass Wenger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Henry L. Schwartz Department of Geriatrics and Adult Development, The Mount Sinai Medical Center, 10029-6574, New York, NY, USA

    Christine K. Cassel M.D. (Professor and Chairman) & Diane E. Meier M.D. (Associate Professor) (Professor and Chairman) &  (Associate Professor)

  2. Center for Study of Aging and Geriatric Research Education and Clinical Center, Duke University Medical Center, 27710, Durham, NC, USA

    Harvey J. Cohen M.D. (Director) (Director)

  3. University of Washington Medical Center, 98195, Seattle, WA, USA

    Eric B. Larson M.D., M.P.H. (Medical Director) (Medical Director)

  4. Gerontology Division, Harvard Medical School, Brigham and Women’s Hospital, 02115, Boston, MA, USA

    Neil M. Resnick M.D. (Chief) (Chief)

  5. Geriatric Research Education and Clinical Center, Sepulveda VA Medical Center, 91343, Sepulveda, CA, USA

    Laurence Z. Rubenstein M.D., M.P.H. (Director) (Director)

  6. Department of Medicine, University of Chicago, 60637, Chicago, IL, USA

    Leif B. Sorensen M.D. (Professor and Vice Chairman) (Professor and Vice Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wenger, N.K. (1997). Cardiovascular Disease. In: Cassel, C.K., et al. Geriatric Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2705-0_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2705-0_26

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-2707-4

  • Online ISBN: 978-1-4757-2705-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation